期刊文献+

影响老年人肝内胆管细胞癌手术预后的因素分析 被引量:1

Factors influencing postoperative prognosis of elderly patients with intrahepatic cholangiocarcinoma
下载PDF
导出
摘要 目的探讨老年肝内胆管细胞癌手术治疗预后相关因素,提高其诊断和治疗水平。方法回顾性对比分析我院1988年10月至2007年10月手术治疗的老年(≥65岁)肝内胆管细胞癌36例与非老年(<65岁)肝内胆管细胞癌32例的临床资料。采用Kaplan-Meier法统计术后生存期并进行单因素分析,Cox回归法进行多因素分析。结果老年组行根治性切除者1、3、5年生存率与行姑息性切除者相较,差异有统计学意义(P<0.01);CEA>10μg/L者1、3、5年生存率与≤10μg/L者相较差异有统计学意义(P<0.01)。多因素分析根治性切除术、CEA是术后生存的独立影响因素。结论老年人肝内胆管细胞癌以手术治疗为主,CEA水平和根治性切除术是影响其预后的主要因素。 Objective To investigate factors influencing postoperative prognosis of elderly patients with intrahepatic cholangiocarcinoma(ICC)in order to improve clinical diagnosis and treatment. Methods A retrospective analysis of consecutive 36 elderly patients(≥65 years old)undergoing hepatectomy for ICC from Oct. 1988 to Oct. 2007 was performed, and 32 patients younger than 65 years served as controls. The data were analyzed by Kaplan-Meier method and Cox regression. Results In the elderly group, the 1-,3- and 5-year survival rate with radical excision was significantly higher than that with non-radical excision(P〈0. 01). The 1-, 3- and 5-year survival rate with a low CEA level(≤ 10 μg/L)was significantly higher than that with a high CEA level(〉10 μg/L, P〈0. 01 ). Multifactor analysis with the Cox proportional-hazards model indicated that radical excision, and CEA level were independent factors influencing the prognosis. Conclusion Operation is the major treatment for the elderly patients with ICC. CEA level and radical excision are major factors influencing the prognosis of elderly ICC patients.
出处 《腹部外科》 2009年第4期238-240,共3页 Journal of Abdominal Surgery
关键词 肝细胞 肝切除术 预后 Carcinoma, hepatocellular Hepatectomy Prognosis
  • 相关文献

参考文献1

二级参考文献27

  • 1[1]Khan SA,Tavlor-Robinson SD,Toledano MB,Beck A,Elliott P,Thomas HC.Changing international trends in mortality rates for liver,biliary and pancreatic tumours.J Hepatol 2002; 37:806-813
  • 2[2]Patel T.Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States.Hepatology 2001; 33:1353-1357
  • 3[3]de Groen PC,Gores GJ,LaRusso NF,Gunderson LL,Nagorney DM.Biliary tract cancers.N Engl J Med 1999; 341:1368-1378
  • 4[4]Jarnagin WR,Fong Y,DeMatteo RP,Gonen M,Burke EC,Bodniewicz BS J,Youssef BA M,Klimstra D,Blumgart LH.Staging,resectability,and outcome in 225 patients with hilar cholangiocarcinoma.Ann Surg 2001; 234:507-517; discussion 517-519
  • 5[5]Ebata T,Nagino M,Kamiya J,Uesaka K,Nagasaka T,Nimura Y.Hepatectomy with portal vein resection for hilarcholangiocarcinoma:audit of 52 consecutive cases.Ann Surg 2003; 238:720-727
  • 6[6]Singh P,Patel T.Advances in the diagnosis,evaluation and management of cholangiocarcinoma.Curr Opin Gastroenterol 2006; 22:294-299
  • 7[7]Khan SA,Thomas HC,Davidson BR,Taylor-Robinson SD.Cholangiocarcinoma.Lancet 2005; 366:1303-1314
  • 8[8]Bismuth H,Nakache R,Diamond T.Management strategies in resection for hilar cholangiocarcinoma.Ann Surg 1992; 215:31-38
  • 9[9]Parker SL,Tong T,Bolden S,Wingo PA.Cancer statistics,1996.CA Cancer J Clin 1996; 46:5-27
  • 10[10]Nakeeb A,Pitt HA,Sohn TA,Coleman J,Abrams RA,Piantadosi S,Hruban RH,Lillemoe KD,Yeo CJ,Cameron JL.Cholangiocarcinoma.A spectrum of intrahepatic,perihilar,and distal tumors.Ann Surg 1996; 224:46,3-473; discussion 473-475

共引文献2

同被引文献17

  • 1Amini Ns Ejaz A,Spolverato Gvet al. Temporal trends in liver-directed therapy of patients with intrahepatic cholangiocarcinoma in the United States, A population-based analysis. J Surg Oneal, 2014,110,163-170.
  • 2Nakeeb A,Pitt HA,Sohn TA,et al, Cholangiocarcinoma-A spectrum of intraqepatic, perihilar, and distal tumors. Ann Surg. 1996,224,463-473.
  • 3Patel T. Worldwide trends in mortality from biliary tract malignancies. BMC Cancer, 2002,2, 10.
  • 4de Jong MC, Nathan H, Sotiropoulos GC, et al. Intrahepatic Cholangiocarcinoma.An international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oneal, 2011 ,29:3140-3145.
  • 5Yamashita y, Taketomi A,Morita Kvet al. The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma, retrospective analysis of 60 patients. Anticancer Res, 2008 ,28,2353-2359.
  • 6Morine Y, Shimada M, Utsunomiya T, et al, Clinical impact of lymph node dissection in surgery for peripheral-type intrahepatic cholangiocarcinoma. Surgery Today,2012,42, 147-151.
  • 7Shimada Ms amashita Yv Aishima Sv et al. Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma. Briti J Surg , 2001 ,88, 1463-1466.
  • 8Ribero D, Pinna AD, Guglielmi A, et al. Surgical approach for long-term survival of patients with intrahepatic cholangiocarcinorna. a multi-institutional analysis of 434 patients. Arch Surg , 2012, 147,1107-1113.
  • 9Bridgewater J, Galle PR, Khan SA, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol , 2014,60,1268-1289.
  • 10Shen WF,Zhong W,Liu Q,et al. Adjuvant transcatheter arterial chemoembolization for intrahepatic cholangiocarcinoma after curative surgery: retrospective control study. World J Surg, 2011, 35,2083-2091.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部